NeuroOne Regains Nasdaq Compliance with 1-for-6 Reverse Split
NeuroOne Medical Technologies has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed above the $1 minimum bid price requirement, closing the listing qualification matter. The Company effected a 1-for-6 reverse stock split effective April 15, 2026, with shares trading under a new CUSIP.
1. Regains Nasdaq Compliance
On May 4, 2026, NeuroOne received notification that it regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed above the $1 minimum bid price requirement, and the listing qualification matter is now closed.
2. Implements 1-for-6 Reverse Stock Split
Effective at 5:00 p.m. ET on April 15, 2026, NeuroOne completed a 1-for-6 reverse stock split; its common stock reopened on April 16 on a split-adjusted basis under the symbol NMTC and a new CUSIP number 64130M308.